As of 2025-05-09, the Fair Value of Brickell Biotech Inc (BBI) is -39.76 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.35 USD, the upside of Brickell Biotech Inc is -1,791.90%.
With the market price of 2.35 USD and our fair value calculation, Brickell Biotech Inc (BBI) is not a good investment. Investing in BBI stocks now will result in a potential loss of 1,791.90%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -39.47 | -21.10 | - | - | -30.29 | |
| YoY growth | -88.75% | 46.54% | - | - | -21.11% | |
| Market Cap (mil) | 6.24 |
| P/E | |
| Forward P/E |
| EPS | -7.95 |
| Avg earnings growth rate | -21.11% |
| TTM earnings | -21.10 |